2019 annual financial data
Corcept Therapeutics 2019 Operating cash flow growth
Direct answer
Operating cash flow growth was 17.68%.
Operating income was 111,606,000 USD and net income was 94,181,000 USD.
Operating cash flow was 136,117,000 USD.
Get free Corcept Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 306,486,000 USD
- Operating income
- 111,606,000 USD
- Net income
- 94,181,000 USD
- Operating cash flow
- 136,117,000 USD